Improving the spontaneous reporting of suspected adverse drug reactions: An overview of systematic reviews

被引:1
|
作者
Routledge, Philip Alexander [1 ]
Bracchi, Robert [2 ]
机构
[1] Cardiff Univ, Sch Med, Cardiff, Wales
[2] Univ Hosp Llandough, All Wales Therapeut & Toxicol Ctr, Llandough, Wales
关键词
adverse drug reaction reports; overview; systematic reviews; CLUSTER-RANDOMIZED TRIAL; TIME-SERIES ANALYSIS; THROMBOTIC MICROANGIOPATHY; EDUCATIONAL INTERVENTION; PHARMACOVIGILANCE; STRATEGIES; PHYSICIANS; PROGRAM;
D O I
10.1111/bcp.15791
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
AimTo conduct an overview of systematic reviews examining interventions to stimulate spontaneous reporting of suspected adverse drug reactions (ADRs) by healthcare professionals (HCPs) and/or patients/carers. MethodsSystematic reviews published since 1 January 2000 were identified and the included publications categorized in relation to the 4Es (education, engineering, economics and enforcement). ResultsAlmost all studies were aimed at HCPs. Educational initiatives were most often used and, in most studies, were associated with improvements in quantity and/or quality of reports, at least in the short term. Lectures/presentations and regular reminders (eg, verbal or by e-mail) were the educational methods most often identified by systematic reviews. Engineering initiatives were also generally effective, including improving the availability of reporting forms, electronic ADR reporting, modification of reporting procedures/policies or the reporting form and assistance to complete the form. Evidence for the benefit of economic incentives (eg, monetary rewards, lottery tickets, days off work, "giveaways" and educational credits) was often clouded by the potential effects of other concomitant initiatives, and any possible associated improvements often disappeared rapidly after incentives were discontinued. ConclusionEducational and engineering strategies appear to be the interventions most often associated with improvements in reporting rates by HCPs, at least in the short to medium term. However, the evidence for sustained impact is weak. The available data were insufficient to clearly identify the separate impact of economic strategies. Further work is also needed to examine the effects of these strategies on reporting by patients, carers and the public.
引用
收藏
页码:2377 / 2385
页数:9
相关论文
共 50 条
  • [41] SPONTANEOUS REPORTING OF ADVERSE DRUG REACTIONS IN GERIATRIC PATIENTS IN INDIA
    Gupta, S. K.
    Gakhar, S.
    Kalaiselvan, V
    Prasad, T.
    Singh, G. N.
    VALUE IN HEALTH, 2014, 17 (07) : A754 - A754
  • [42] Parental reporting of suspected adverse drug reactions in children in Lagos, Nigeria
    Oshikoya, K. A.
    Senbanjo, I. O.
    Njokanma, O. F.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2009, 94 (06) : 469 - 473
  • [43] Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway
    Granas, Anne G.
    Buajordet, Marit
    Stenberg-Nilsen, Hanne
    Harg, Pernille
    Horn, Anne M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (04) : 429 - 434
  • [44] Suspected Adverse Drug Reactions Related to Breast Cancer Chemotherapy: Disproportionality Analysis of the Brazilian Spontaneous Reporting System
    Barcelos, Flavia Campos
    de Matos, Guacira Correa
    Sobreira da Silva, Mario Jorge
    Barbosa da Silva, Fabricio Alves
    Lima, Elisangela da Costa
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [45] Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future
    Alomar, Muaed
    Tawfiq, Ali M.
    Hassan, Nageeb
    Palaian, Subish
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2020, 11
  • [46] Publishing histories of adverse reactions to medicaments - Anecdotally the PHARMA guidelines for reporting suspected adverse drug reactions
    Aronson, Jeffrey K.
    DRUG SAFETY, 2008, 31 (04) : 355 - 356
  • [47] Publishing Histories of Adverse Reactions to Medicaments AnecdotallyThe PHARMA guidelines for Reporting Suspected Adverse Drug Reactions
    Jeffrey K. Aronson
    Drug Safety, 2008, 31 : 355 - 356
  • [48] Adverse Event Reporting for Proton Pump Inhibitor Therapy: An Overview of Systematic Reviews
    Abramowitz, Jason
    Thakkar, Punam
    Isa, Arton
    Truong, Alan
    Park, Connie
    Rosenfeld, Richard M.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2016, 155 (04) : 547 - 554
  • [49] Reporting of adverse events of treatment interventions in multiple myeloma: an overview of systematic reviews
    Mainou, Maria
    Bougioukas, Konstantinos I.
    Malandris, Konstantinos
    Liakos, Aris
    Klonizakis, Philippos
    Avgerinos, Ioannis
    Haidich, Anna-Betinna
    Tsapas, Apostolos
    ANNALS OF HEMATOLOGY, 2024, 103 (08) : 2681 - 2697
  • [50] Adverse drug reactions on sexual functioning: a systematic overview
    Gordijn, Rineke
    Teichert, Martina
    Nicolai, Melianthe P. J.
    Elzevier, Henk W.
    Guchelaar, Henk-Jan
    DRUG DISCOVERY TODAY, 2019, 24 (03) : 890 - 897